Chronic GVHD Linked to Nonmalignant Late Effects in Pediatric Cancer Survivors
Chronic GVHD is associated with nonmalignant late effects, but not subsequent neoplasms, in pediatric cancer survivors.
Pediatric Cancer
PEDIATRIC CANCER ADVISOR
FEATURED CONTENT
-
-
Links Between Parental Exposure to Pesticides, Childhood Cancer Explored
Researchers observed a higher risk of lymphoma and solid tumors in children of mothers exposed to pesticides, as well as an increased risk of myeloid leukemia in children of fathers exposed to insecticides. -
Childhood Cancer Survivors Have Increased Risk of Inpatient Infections
Childhood cancer survivors have an increased risk of inpatient infections 5 years or more after their cancer diagnosis. -
Genetic Alterations ID’d in Many Pediatric Solid Tumors
Researchers found clinically significant genetic variations in 86% of pediatric patients with extracranial solid tumors. -
Durvalumab Plus Tremelimumab in Pediatric Patients With Advanced Cancers
Researchers are conducting a phase 1/2 trial to evaluate durvalumab plus tremelimumab in pediatric patients with advanced cancers.
PEDIATRIC CANCER NEWS
Higher Tisagenlecleucel Doses May Improve Outcomes in Youth With B-ALL
Avapritinib in Pediatric Patients With Solid Tumors, Glioma
Alectinib in Patients With ALK Fusion-Positive Solid, CNS Tumors
Memantine for Neurocognitive Protection in Children Undergoing Cranial Radiotherapy
Race, Ethnicity Underreported in Early Phase Pediatric Cancer Trials
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in News
Loading... 
Loading...